Home > Healthcare > Drug Device Combination > Therapeutic Systems > Dacryocystitis Market
Dacryocystitis Market Size
- Report ID: GMI9588
- Published Date: May 2024
- Report Format: PDF
Dacryocystitis Market Size
Dacryocystitis Market size was valued at USD 40.6 million in 2023 and is anticipated to showcase growth at 5.2% CAGR from 2024 and 2032. Increasing prevalence of chronic and congenital dacryocystitis, growing awareness towards advanced ophthalmic treatment options, and increasing ageing population is driving the demand for dacryocystitis treatments. Additionally, availability of advanced diagnostic techniques to timely diagnose dacryocystitis has also contributed to the revenue growth in market.
Dacryocystitis is a condition marked by inflammation or infection of the lacrimal sac, a small pouch situated at the inner corner of the eye where tears gather before flowing into the nasolacrimal duct. Market covers medication and surgical devices utilized in the treatment of dacryocystitis.
| Report Attribute | Details |
|---|---|
| Base Year: | 2023 |
| Dacryocystitis Market Size in 2023: | USD 40.6 Million |
| Forecast Period: | 2024 – 2032 |
| Forecast Period 2024 – 2032 CAGR: | 5.2% |
| 2024 – 2032 Value Projection: | USD 63.5 Million |
| Historical Data for: | 2021 – 2023 |
| No. of Pages: | 111 |
| Tables, Charts & Figures: | 204 |
| Segments covered: | Treatment, Indication, Distribution channel, and Region |
| Growth Drivers: |
|
| Pitfalls & Challenges: |
|
Frequently Asked Questions (FAQ) :
Dacryocystitis Market Scope
